Facebook Twitter LinkedIn Google Plus RSS

ADMA Biologics prices IPO

By ,

Ramsey-based ADMA Biologics Inc. announced Thursday pricing for its initial public offering.

According to the announcement, the biopharmaceutical company will offer 3.35 million shares of its common stock at a public offering price of $8.50 per share. The company has granted the underwriters a 30-day option to purchase up to an additional 502,941 shares of common stock at the same price to cover over-allotments, if any.

Oppenheimer & Co. is acting as sole book-running manager for the offering. Ladenburg Thalmann & Co. Inc., Maxim Group LLC and Laidlaw & Co. Ltd. are acting as co-managers. The offering is expected to close on Oct. 22, subject to customary closing conditions, the company said in a statement.


More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!